BUDDY & LOLA LIMITED

Company number 13245562 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BUDDY & LOLA LIMITED - Analysis Report

Company Number: 13245562

Analysis Date: 2025-07-20 18:14 UTC

Financial Health Assessment for Buddy & Lola Limited


1. Financial Health Score: D

Explanation:
The company is exhibiting clear signs of financial stress, marked by persistent net current liabilities and negative net assets over multiple years. While operational activity is evident, the balance sheet shows ongoing erosion of shareholder funds. The score reflects a fragile financial position requiring urgent attention to avoid further deterioration.


2. Key Vital Signs

Metric 2024 Value Interpretation
Net Current Assets (Working Capital) £-611,468 Negative working capital ("symptom of cash flow distress") indicating liabilities exceed short-term assets, risking liquidity issues.
Net Assets (Shareholders’ Funds) £-611,095 Negative net assets ("deficit in financial health") showing liabilities outweigh total assets, a critical warning sign.
Cash at Bank £10,444 Very low cash reserve relative to current liabilities, insufficient buffer for immediate obligations.
Share Capital £94 (Nominal) Minimal capital investment; company relies heavily on external or shareholder loans.
Trade Debtors £321,256 Significant receivables, but risk of delayed collections impacting cash flow.
Current Liabilities £1,070,962 Very high short-term obligations, indicating pressure on liquidity.
Stock £127,794 Inventory growing, but may tie up cash and risk obsolescence if not managed.
Related Party Loans £142,400 owed to associates + £50,000 to director Indicates reliance on related parties for financing, which can be a lifeline but also a risk if external funding is limited.
Profit & Loss Reserve £-800,877 Large accumulated losses ("chronic financial illness") indicating sustained unprofitability.

3. Diagnosis

Buddy & Lola Limited is facing significant financial strain characterized by:

  • Liquidity challenges: The company’s negative working capital suggests it does not have enough current assets (cash, receivables, stock) to cover its immediate liabilities. This creates a "cash flow blockage" symptom that could impair day-to-day operations unless addressed.

  • Balance sheet weakness: Negative net assets mean the company’s total liabilities exceed its assets, signifying insolvency on a balance sheet basis. This is a serious "health condition" indicating the company is technically insolvent, dependent on shareholder or creditor support to continue.

  • Dependence on related parties: The company owes large sums to related entities and a director, highlighting reliance on internal funding rather than external credit or operational cash flows. While this can provide a temporary lifeline, it may not be sustainable long-term without improved trading results.

  • Asset composition concerns: Substantial stock and debtors suggest funds are tied up in inventory and receivables, which may not convert quickly to cash. Slow collections or overstocking can exacerbate liquidity problems.

  • Operating outlook: No profit and loss account is provided, but the persistent losses embedded in reserves suggest ongoing operational challenges or startup phase losses. The going concern note mentions reliance on shareholder funding, indicating limited operational cash generation.


4. Recommendations

Immediate Actions ("Emergency Treatment"):

  • Improve liquidity management: Focus on accelerating debtor collections and reducing stock levels to free up cash. Consider stricter credit control and inventory optimization.

  • Negotiate creditor terms: Engage with suppliers and related parties to extend payment terms or restructure liabilities to ease short-term cash flow pressures.

  • Increase cash reserves: Explore options for additional equity injection or external financing to strengthen the cash position and provide a buffer.

Medium-Term Strategies ("Recovery Plan"):

  • Cost control: Review operating expenses to reduce burn rate and improve margins.

  • Revenue growth: Implement strategies to increase sales, focusing on higher-margin products or services.

  • Financial monitoring: Set up regular financial health checks ("vital signs monitoring") to track key metrics and detect early symptoms of distress.

  • Governance and transparency: Ensure clear communication with shareholders and creditors about financial status and plans.

If these steps are not effectively implemented, the prognosis points to worsening financial health, increasing risk of insolvency or forced restructuring.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.